Symbiosis Bioscience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 07-11-2024
- Paid Up Capital ₹ 0.10 M
as on 07-11-2024
- Company Age 2 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.50 Cr
as on 07-11-2024
- Satisfied Charges ₹ 5.85 M
as on 07-11-2024
About Symbiosis Bioscience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.50 Cr. The company has closed loans amounting to ₹5.85 M, as per Ministry of Corporate Affairs (MCA) records.
Jagdish Hirani, Kuldeep Ribadiya, Rushikumarkanaiyalal Ribadiya, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24304GJ2022PTC134050
- Company No.
134050
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jul 2022
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Symbiosis Bioscience?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagdish Hirani  | Additional Director | 17-Oct-2023 | Current |
| Kuldeep Ribadiya | Additional Director | 17-Oct-2023 | Current |
| Rushikumarkanaiyalal Ribadiya | Additional Director | 17-Oct-2023 | Current |
| Sagar Hirani | Director | 20-Jul-2022 | Current |
| Sakshi Laller | Additional Director | 17-Oct-2023 | Current |
Financial Performance and Corporate Structure Insights of Symbiosis Bioscience.
Symbiosis Bioscience Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Symbiosis Bioscience?
Unlock access to Symbiosis Bioscience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Axter Pharmaceuticals Private LimitedActive 10 years 3 monthsJagdish Hirani, Kuldeep Ribadiya and 2 more are mutual person
Lifekyor Overseas Private LimitedActive 7 years 2 monthsJagdish Hirani and Rushikumarkanaiyalal Ribadiya are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 19 Dec 2023 | ₹7.50 M | Open |
Axis Bank Limited Creation Date: 07 Dec 2023 | ₹7.50 M | Open |
Hdfc Bank Limited Creation Date: 10 Apr 2023 | ₹5.85 M | Satisfied |
How Many Employees Work at Symbiosis Bioscience?
Symbiosis Bioscience has a workforce of 0 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Symbiosis Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Symbiosis Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
